CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-01 | Schlanger David J Executive Chairman | Sale | −5,812 | $45.00 | $262K | 82,748 |
| 2022-11-01 | Schlanger David J Executive Chairman | Sale | −200 | $45.91 | $9K | 82,548 |
| 2022-11-01 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −41,667 | 1,317,013 | ||
| 2022-11-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +16,000 | $3.95 | $63K | 266,445 |
| 2022-11-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −14,154 | $44.10 | $624K | 252,291 |
| 2022-11-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −1,846 | $45.07 | $83K | 250,445 |
| 2022-11-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −3,537 | $44.10 | $156K | 173,061 |
| 2022-11-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −463 | $45.07 | $21K | 172,598 |
| 2022-11-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −16,000 | 1,419,555 | ||
| 2022-10-27 | Payson Norman Director | Sale | −900 | $40.68 | $37K | 331,099 |
| 2022-10-27 | Payson Norman Director | Sale | −5,717 | $41.43 | $237K | 325,382 |
| 2022-10-26 | Payson Norman Director | Sale | −3,884 | $41.08 | $160K | 334,732 |
| 2022-10-26 | Payson Norman Director | Sale | −2,333 | $41.98 | $98K | 332,399 |
| 2022-10-26 | Payson Norman Director | Sale | −400 | $42.52 | $17K | 331,999 |
| 2022-10-26 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +3,910 | $3.95 | $15K | 254,355 |
| 2022-10-26 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −400 | $40.71 | $16K | 253,955 |
| 2022-10-26 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −1,125 | $42.29 | $48K | 250,445 |
| 2022-10-26 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −100 | $40.71 | $4K | 177,475 |
| 2022-10-26 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −596 | $41.27 | $25K | 176,879 |
| 2022-10-26 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −281 | $42.29 | $12K | 176,598 |
Page 37 of 77 · 1,524 trades